Skip to main content

Tag: PET

Tau PET Imaging in Drug Development – Dr. Eric Hostetler

Tau proteins (named after the Greek letter T) are commonly associated with chronic neurodegenerative diseases such as Alzheimer’s disease (AD) and traumatic brain injuries. Positron Emission Tomography (PET), a non-invasive imaging technology, is used to measure disruptive tau accumulations in the brain. Currently there are few available PET tracers that can be used to measure […]

Innovative ALS Imaging Biomarkers Come Closer to Patients

Researchers at Massachusetts General Hospital (MGH) have successfully used PET imaging to measure inflammation in the brain of a person living with amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which […]

Gordon Center Symposium Addresses Challenges and Innovations in Simultaneous PET/MR Imaging

The Gordon Center for Medical Imaging hosted the Frontiers in PET/MR Symposium on March 25, 2016 at the Massachusetts General Hospital (MGH). Invited lecturers from different disciplines including radiology, physics, bio-engineering and oncology discussed challenges, opportunities, technology and clinical translation in simultaneous PET/MR imaging. The Gordon Center lectures were conducted in parallel with the Hampton Symposium 2016 thanks to the […]

Molecular Imaging Pushes Boundaries of Personalized Medicine

Researchers at the Gordon Center for Medical Imaging are using molecular imaging and nuclear medicine technology to push the boundaries of personalized medicine. We talked to Dr. Rachid Akiki, MD, who is working closely with Dr. Marc Normandin, PhD, in the Gordon Center of the Radiology Department, to find out how. What is molecular imaging? […]